Literature DB >> 1546925

The prevalence and incidence of lower extremity amputation in a diabetic population.

S E Moss1, R Klein, B E Klein.   

Abstract

OBJECTIVE: To describe the incidence of lower extremity amputations and sores or ulcers and investigate risk factors for these complications.
DESIGN: Cohort.
SETTING: Primary care. PARTICIPANTS: Population-based sample (N = 1210) of younger-onset diabetic persons (diagnosed before age 30 years and taking insulin) and a stratified random sample (N = 1780) of older-onset diabetic persons (diagnosed after age 30 years). Baseline and 4-year follow-up examinations were completed by 996 and 891 younger-onset persons, respectively, and by 1370 and 987 older-onset persons, respectively. MAIN OUTCOME MEASURES: Amputations and sores or ulcers of the lower extremities.
RESULTS: Four-year incidence of amputations was 2.2% in both groups. Incidence of sores or ulcers was 9.5% in younger-onset and 10.5% in older-onset persons. In younger-onset persons, significant risk factors for amputation with odds ratios (and 95% confidence intervals) include age, 2.0 for 10 years (1.2 to 3.1), history of sores or ulcers, 10.5 (3.7 to 29.8), diastolic blood pressure, 2.1 for 10 mm Hg (1.3 to 3.5), and pack-years smoked, 1.3 for 10 years (1.0 to 1.6). Risk factors for sores or ulcers include glycosylated hemoglobin, 1.6 for 2% (1.3 to 2.0), retinopathy, 1.3 for two steps (1.1 to 1.6), and current smoking, 2.3 (1.0 to 5.6). In older-onset persons, risk factors for amputation are history of sores or ulcers, 4.6 (1.7 to 12.2), proteinuria, 4.3 (1.6 to 11.5), glycosylated hemoglobin, 1.5 for 2% (1.0 to 2.2), sex, 2.8 for males (1.0 to 7.5), and duration of diabetes, 1.8 for 10 years (1.0 to 3.2). For sores or ulcers, risk factors are glycosylated hemoglobin, 1.6 for 2% (1.3 to 2.0), duration, 1.5 for 10 years (1.0 to 2.1), proteinuria, 2.2 (1.1 to 4.3), and diastolic blood pressure, 0.8 for 10 mm Hg (0.6 to 1.0).
CONCLUSIONS: Several factors offer potential for modification for the prevention of amputations but require further study. These include blood pressure, glycosylated hemoglobin, and smoking.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1546925

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  35 in total

1.  The major predictors of amputation and length of stay in diabetic patients with acute foot ulceration.

Authors:  Suzan Tabur; Mehmet Ali Eren; Yakup Çelik; Omer Faruk Dağ; Tevfik Sabuncu; Zeynel Abidin Sayiner; Esen Savas
Journal:  Wien Klin Wochenschr       Date:  2014-11-15       Impact factor: 1.704

Review 2.  Risk assessment of the diabetic foot and wound.

Authors:  Stephanie Wu; David G Armstrong
Journal:  Int Wound J       Date:  2005-03       Impact factor: 3.315

3.  Requisite models for strategic commissioning: the example of type 1 diabetes.

Authors:  Mara Airoldi; Gwyn Bevan; Alec Morton; Mónica Oliveira; Jenifer Smith
Journal:  Health Care Manag Sci       Date:  2008-06

4.  Laterality of lower limb amputation in diabetic patients: retrospective audit.

Authors:  J P Coxon; I W Gallen
Journal:  BMJ       Date:  1999-02-06

5.  Risk factors for major amputation in hospitalised diabetic foot patients.

Authors:  Sik Namgoong; Suyoung Jung; Seung-Kyu Han; Seong-Ho Jeong; Eun-Sang Dhong; Woo-Kyung Kim
Journal:  Int Wound J       Date:  2015-10-19       Impact factor: 3.315

Review 6.  Diabetic foot syndrome: Immune-inflammatory features as possible cardiovascular markers in diabetes.

Authors:  Antonino Tuttolomondo; Carlo Maida; Antonio Pinto
Journal:  World J Orthop       Date:  2015-01-18

7.  Diabetic foot complications and their risk factors from a large retrospective cohort study.

Authors:  Khalid Al-Rubeaan; Mohammad Al Derwish; Samir Ouizi; Amira M Youssef; Shazia N Subhani; Heba M Ibrahim; Bader N Alamri
Journal:  PLoS One       Date:  2015-05-06       Impact factor: 3.240

8.  The cost effectiveness of Apligraf treatment of diabetic foot ulcers.

Authors:  W Ken Redekop; Joseph McDonnell; Paul Verboom; Kornelia Lovas; Zoltan Kalo
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

Review 9.  The efficacy of aldose reductase inhibitors in the management of diabetic complications. Comparison with intensive insulin treatment and pancreatic transplantation.

Authors:  J M van Gerven; A M Tjon-A-Tsien
Journal:  Drugs Aging       Date:  1995-01       Impact factor: 3.923

10.  Independent risk factors for amputation in diabetic foot.

Authors:  Abolfazl Shojaiefard; Zhamak Khorgami; Bagher Larijani
Journal:  Int J Diabetes Dev Ctries       Date:  2008-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.